Boston Scientific Corporation
Boston Scientific Corporation (BSX) Stock Overview
Explore Boston Scientific Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
102.6B
P/E Ratio
35.68
EPS (TTM)
$1.94
ROE
0.13%
BSX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Boston Scientific Corporation (BSX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 30.08, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $103.32.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 35.68 and a market capitalization of 102.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.